Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Katherine Littler

Co-Lead, Global Health Ethics & Governance Unit, World Health Organisation

I am currently the co-lead of the Global Health Ethics & Governance Unit at WHO Headquarters, Geneva. I am passionate about embedding ethics more effectively in global health ethics decision making and increasing ethics capacity around the globe. Whilst a lot of my current focus is on COVID-related work, I am also focused on supporting the realization of the potential benefits of emerging technologies in different settings via the development of governance mechanisms; the ethics of clinical trial design, with particular reference to  human challenge studies and identifying gaps in ethical oversight in global health. 
Prior to joining WHO in 2018, I co-led the Global Policy Team at Wellcome, where I provided strategic advice on regulatory, governance and ethical issues. At Wellcome, I led a programme of work focusing on research ethics, global governance and advocacy, epidemic preparedness, genomics and emerging technologies, and evidence into policy. I was involved in international partnerships and sat on many oversight bodies, including: the PHE Ebola Governance Group; the IDDO Ebola Platform Steering Committee; the H3Africa Ethics and Regulatory Working Group and I was the chair of the GLOPID-R data sharing working group.